TILT Holdings (TLLTF) Shares Outstanding (Weighted Average) (2021 - 2025)
TILT Holdings (TLLTF) reported Shares Outstanding (Weighted Average) of $391.3 million for Q2 2025, up 1.07% on a YoY basis from $387.1 million in Q2 2024, and little changed quarter-over-quarter from $391.3 million in Q1 2025.
TILT Holdings (TLLTF) Shares Outstanding (Weighted Average) (2021 - 2025) Analysis & Trends
TILT Holdings has reported Shares Outstanding (Weighted Average) for 5 years, with the latest figure at $391.3 million in Q2 2025.
- For the quarter ending Q2 2025, Shares Outstanding (Weighted Average) rose 1.07% year-over-year to $391.3 million; the trailing twelve-month figure through Jun 2025 stood at $391.3 million (up 1.07% YoY), and the FY2024 full-year result was $388.7 million, up 2.4% from the prior year.
- Shares Outstanding (Weighted Average) for Q2 2025 stood at $391.3 million, roughly flat from $391.3 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $391.3 million in Q2 2025, with the low at $9.5 million in Q4 2022.
- Historically, Shares Outstanding (Weighted Average) has averaged $340.5 million across 5 years, with a median of $378.3 million in 2023.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) sank 87.08% — and 2023, when it surged 3876.43%.
- TILT Holdings' Shares Outstanding (Weighted Average) stood at $73.9 million in 2021, then slumped by 87.08% to $9.5 million in 2022, then surged by 3876.43% to $379.6 million in 2023, then climbed by 2.4% to $388.7 million in 2024, then grew by 0.66% to $391.3 million in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $391.3 million (Q2 2025), $391.3 million (Q1 2025), and $388.7 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 64.74 Mn |
| 10 | TILT Holdings | - | - | 1.82 Mn | 391.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 391.26 Mn |
| Mar 31, 2025 | 391.25 Mn |
| Dec 31, 2024 | 388.71 Mn |
| Sep 30, 2024 | 387.92 Mn |
| Jun 30, 2024 | 387.10 Mn |
| Mar 31, 2024 | 385.72 Mn |
| Dec 31, 2023 | 379.58 Mn |
| Sep 30, 2023 | 378.54 Mn |
| Jun 30, 2023 | 378.30 Mn |
| Mar 31, 2023 | 377.70 Mn |
| Dec 31, 2022 | 9.55 Mn |
| Sep 30, 2022 | 375.31 Mn |
| Jun 30, 2022 | 375.54 Mn |
| Mar 31, 2022 | 374.61 Mn |
| Dec 31, 2021 | 73.91 Mn |
| Sep 30, 2021 | 371.06 Mn |
| Jun 30, 2021 | 361.64 Mn |